Endocanna Health Granted Patent For DNA Test That Could Prevent Weed-Related ER Visits
Endocanna Health, an industry leader in endocannabinoid system genomic testing, has been granted a first-of-its-kind U.S. patent for its DNA test, enabling hyper-personalized cannabinoid therapies based on user genetics.
